BioMark Diagnostics Inc.
BUX
Classement en actions
#26647
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Prix de l'action
$0.34495034
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$36.73M
Changement (1 jour)
-4.08%
Changement (1 an)
53.78%
Pays
CA
Échange BioMark Diagnostics Inc. (BUX)
Catégorie
Healthcare
Capitalisation boursière de BioMark Diagnostics Inc.(BUX)
Capitalisation boursière: $36.73M
En October 2026, BioMark Diagnostics Inc. a une capitalisation boursière de $36.73M. Cela fait de BioMark Diagnostics Inc. la 26647th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BioMark Diagnostics Inc. du 2015 au 2026
BUX par rapport au top 5 des plus populaires stocks
| Prix pour BUX | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$48,524.55
$40.13M
|
$5.167T | +12,874,549.30% | ||
|
$47,094.65
$40.13M
|
$5.015T | +12,495,162.86% | ||
|
$38,582.71
$40.13M
|
$4.108T | +10,236,754.73% | ||
|
$36,643.44
$40.13M
|
$3.902T | +9,722,225.06% | ||
|
$25,257.14
$40.13M
|
$2.689T | +6,701,184.17% |
